Avantax Planning Partners Inc. Has $549,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Avantax Planning Partners Inc. grew its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,051 shares of the medical equipment provider’s stock after purchasing an additional 89 shares during the quarter. Avantax Planning Partners Inc.’s holdings in Intuitive Surgical were worth $549,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of ISRG. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the 4th quarter worth about $26,000. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $28,000. Kohmann Bosshard Financial Services LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at $31,000. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical during the 3rd quarter worth $33,000. Finally, Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical in the fourth quarter valued at about $36,000. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ISRG shares. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. CICC Research began coverage on Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 price objective for the company. Barclays upped their price objective on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Leerink Partners upped their price objective on Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Intuitive Surgical Trading Up 2.3 %

Shares of NASDAQ:ISRG opened at $493.72 on Wednesday. The stock has a market cap of $175.85 billion, a PE ratio of 77.02, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock’s fifty day simple moving average is $569.91 and its two-hundred day simple moving average is $531.84.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,309 shares of company stock worth $7,611,004. 0.90% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.